Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Analysis of drug pharmacology towards predicting drug behavior by expression profiling using high-density oligonucleotide arrays.
Hu JS, Durst M, Kerb R, Truong V, Ma JT, Khurgin E, Balaban D, Gingeras TR, Hoffman BB. Hu JS, et al. Ann N Y Acad Sci. 2000;919:9-15. doi: 10.1111/j.1749-6632.2000.tb06862.x. Ann N Y Acad Sci. 2000. PMID: 11083092
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS, Murty VV. Narayan G, et al. Genes Chromosomes Cancer. 2007 Apr;46(4):373-84. doi: 10.1002/gcc.20418. Genes Chromosomes Cancer. 2007. PMID: 17243165
Detection of cancer-related gene expression profiles in severe cervical neoplasia.
Sopov I, Sörensen T, Magbagbeolu M, Jansen L, Beer K, Kühne-Heid R, Kirchmayr R, Schneider A, Dürst M. Sopov I, et al. Int J Cancer. 2004 Oct 20;112(1):33-43. doi: 10.1002/ijc.20351. Int J Cancer. 2004. PMID: 15305373
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N; Australian Ovarian Cancer Study Group, Baker H, Bandera EV, Bean Y, Beckmann MW, Berchuck A, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Easton DT, Edwards RP, Eilber U, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall C, Hosono S, Iversen ES, Jakubowska A, James P, Jensen A, Ji BT, Karlan BY, Kruger Kjaer S, Kelemen LE, Kellar M, Kelley JL, Kiemeney LA, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Phelan CM, Pike MC, Poole EM, Ramus SJ, Risch HA, Rosen B, Rossing MA, Rothstein JH, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schildkraut JM, Schwaab I, Sellers TA, Shu XO, Shvetsov YB, Siddiqui N, Sieh W, Song H, Southey MC, Sucheston L, Tangen IL, Teo SH, Terry KL, Thompson PJ, Timorek A, Tsai YY, Tworoger SS, van Altena AM, Van Nieuwenhuysen E, Vergote I, Vierkant RA, Wang-Gohrke S, Walsh C, Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Monteiro A, Pharoah PD, Gayther SA, Freedman ML. Lawrenson K, et al. Nat Commun. 2015 Sep 22;6:8234. doi: 10.1038/ncomms9234. Nat Commun. 2015. PMID: 26391404 Free PMC article.
Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D, Hoffmann F, Steinbach D, Jansen L, Mary Photini S, Gajda M, Mosig AS, Sonnemann J, Peters S, Melnikova M, Thomale J, Dürst M, Runnebaum IB, Häfner N. Kritsch D, et al. Int J Cancer. 2017 Oct 15;141(8):1600-1614. doi: 10.1002/ijc.30860. Epub 2017 Jul 12. Int J Cancer. 2017. PMID: 28670762
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression.
Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B, Murty VV. Narayan G, et al. Mol Cancer. 2006 May 15;5:16. doi: 10.1186/1476-4598-5-16. Mol Cancer. 2006. PMID: 16700909 Free PMC article.
p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer.
Häfner N, Nicolaus K, Weiss S, Frey M, Diebolder H, Rengsberger M, Dürst M, Runnebaum IB. Häfner N, et al. J Cancer Res Clin Oncol. 2013 Jul;139(7):1207-10. doi: 10.1007/s00432-013-1432-2. Epub 2013 Apr 11. J Cancer Res Clin Oncol. 2013. PMID: 23576021
Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants.
Ohlschläger P, Quetting M, Alvarez G, Dürst M, Gissmann L, Kaufmann AM. Ohlschläger P, et al. Int J Cancer. 2009 Jul 1;125(1):189-98. doi: 10.1002/ijc.24333. Int J Cancer. 2009. PMID: 19358269
Mass spectrometry meets chip technology: a new proteomic tool in cancer research?
von Eggeling F, Junker K, Fiedle W, Wollscheid V, Dürst M, Claussen U, Ernst G. von Eggeling F, et al. Electrophoresis. 2001 Aug;22(14):2898-902. doi: 10.1002/1522-2683(200108)22:14<2898::AID-ELPS2898>3.0.CO;2-A. Electrophoresis. 2001. PMID: 11565785
233 results
Jump to page
Feedback